Link to this page
Bilingual Ontology of Alzheimer's Disease and Related Diseases
Last uploaded:
December 2, 2013
Jump to:
| Id | http://doe-generated-ontology.com/OntoAD#C0030512
http://doe-generated-ontology.com/OntoAD#C0030512
|
|---|---|
| Preferred Name | Parasympathomimetic Agents |
| Definitions |
Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (source : MSH)
|
| Synonyms |
Parasympathomimetic Drugs
Parasympathomimetic agent
Parasympathomimetics
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. (source : MSH) |
|---|---|
| altLabel |
Parasympathomimetic Drugs
Parasympathomimetic agent
Parasympathomimetics
|
| prefLabel |
Parasympathomimetic Agents
|
| hiddenLabel |
ParasympathomimeticAgents
|
| prefixIRI |
OntoAD:C0030512
|
| subClassOf | |
| type |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |